EGFR c.2274A>T ;(p.E758D)

Variant ID: 7-55242504-A-T

NM_005228.3(EGFR):c.2274A>T;(p.E758D)

This variant was identified in 5 publications

View GRCh38 version.




Publications:


Mucoepidermoid carcinoma (MEC) and adenosquamous carcinoma (ASC), the same or different entities?

Modern Pathology : An Official Journal Of The United States And Canadian Academy Of Pathology, Inc
White, Valerie A VA; Hyrcza, Martin D MD; Lennerz, Jochen K JK; Thierauf, Julia J; Lokuhetty, Dilani D; Cree, Ian A IA; Indave, Blanca Iciar BI
Publication Date: 2022-10

Variant appearance in text: EGFR: E758D
PubMed Link: 35871081
Variant Present in the following documents:
  • 41379_2022_1100_MOESM4_ESM.xlsx, sheet 1
View BVdb publication page



EGFR-dependent mechanisms of resistance to osimertinib determined by ctDNA NGS analysis identify patients with better outcome.

Translational Lung Cancer Research
Vendrell, Julie A JA; Quantin, Xavier X; Aussel, Audrey A; Solassol, Isabelle I; Serre, Isabelle I; Solassol, Jérôme J
Publication Date: 2021-11

Variant appearance in text: EGFR: E758D
PubMed Link: 35004240
Variant Present in the following documents:
  • Main text
View BVdb publication page



The Comprehensive Analyses of Genomic Variations and Assessment of TMB and PD-L1 Expression in Chinese Lung Adenosquamous Carcinoma.

Frontiers In Genetics
Cheng, Yong Y; Zhang, Yanxiang Y; Yuan, Yuwei Y; Wang, Jiao J; Liu, Ke K; Yu, Bin B; Xie, Li L; Ou-Yang, Chao C; Wu, Lin L; Ye, Xiaoqun X
Publication Date: 2020

Variant appearance in text: EGFR: E758D
PubMed Link: 33679868
Variant Present in the following documents:
  • Main text
  • fgene-11-609405.pdf
View BVdb publication page



Landscape of drug-resistance mutations in kinase regulatory hotspots.

Briefings In Bioinformatics
Kim, Pora P; Li, Hanyang H; Wang, Junmei J; Zhao, Zhongming Z
Publication Date: 2021-05-20

Variant appearance in text: EGFR: E758D
PubMed Link: 32510566
Variant Present in the following documents:
  • Main text
View BVdb publication page



Acquired resistance to osimertinib in patients with non-small-cell lung cancer: mechanisms and clinical outcomes.

Journal Of Cancer Research And Clinical Oncology
Mu, Yuxin Y; Hao, Xuezhi X; Xing, Puyuan P; Hu, Xingsheng X; Wang, Yan Y; Li, Teng T; Zhang, Jinyao J; Xu, Ziyi Z; Li, Junling J
Publication Date: 2020-09

Variant appearance in text: EGFR: E758D
PubMed Link: 32385709
Variant Present in the following documents:
  • Main text
  • 432_2020_Article_3239.pdf
View BVdb publication page